Fig. 1

Characterization of disease progression in PCa cases. a Overall survival calculated by the Kaplan Meier method for high-risk with progression (HR + P, blue solid line), high-risk without progression (HR-P, red dotted line) and low-risk (LR, black dashed line) PCa cases. P-value estimated with Log-Rank test. b PSA progression free survival calculated by the Kaplan Meier ethod for HR + P, HR-P and LR PCa cases. P-value estimated with Log-Rank test. c Local progression free survival calculated by the Kaplan Meier method for HR + P, HR-P and LR PCa cases. P-value estimated by the Log-Rank test. d Lymph node progression-free survival calculated by the Kaplan Meier method for HR + P, HR-P and LR PCa cases. P-value estimated by the Log-Rank test. e Bone progression-free survival calculated by the Kaplan Meier method for HR + P, HR-P and LR PCa cases. P-value estimated with the Log-Rank test. For statistical details see Methods section